Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00858312 · ClinicalTrials.gov registry record · NA

Dairy Foods and Weight Loss

A NA study of Overweight and Obesity, sponsored by USDA, Western Human Nutrition Research Center.

Completed
Registry status
NA
Development phase
78
Enrollment target
1
Study location

NCT00858312: Completed NA study of Overweight and Obesity, sponsored by USDA, Western Human Nutrition Research Center.

NCT00858312 is a NA study of Overweight and Obesity that has completed, run by USDA, Western Human Nutrition Research Center. The registered enrollment target is 78 participants, below the 228-participant average among 115 other Overweight and Obesity trials with a reported enrollment target (66% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00858312, a NA study of Overweight and Obesity, has completed, sponsored by USDA, Western Human Nutrition Research Center.

COMPLETED
Registry status
NA
Development phase
78 participants
Enrollment target
1
Study location

Study Summary

Obesity is a national epidemic with multiple causes and complex solutions. Research in both animals and humans has suggested that the inclusion of dairy foods into a moderate calorie restricted diet can increase weight loss and fat loss. Our proposed project extends these prior findings by determining, for the first time, how inclusion of dairy in a calorie-restricted diet changes the amount of visceral adiposity in overweight and obese subjects. The investigators also propose unique studies to evaluate the potential mechanism(s) by which dairy promotes weight and fat loss during dieting, through an examination of adipocyte size, gene expression, and inflammatory markers. The hypotheses under investigation are (1) that inclusion of dairy foods in a modest energy restricted diet will significantly increase body fat loss compared to a control diet; (2) that dairy products in a modest energy restricted diet will result in greater fat loss from intra-abdominal adipose tissue compared to the control, 3) components of dairy products up- or down-regulate the secretion of metabolically-relevant hormones during the postprandial and inter-meal periods, 4) dairy products will promote satiety and/or satiation, 5) dairy foods reduce adipocyte differentiation and/or enhance adipocyte apoptosis, leading to concomitant white adipose tissue (WAT) expression changes for genes playing a role in these processes, 6) dairy foods will reduce adipocyte lipid storage and enhance pathways associated with thermogenesis and mitochondrial function in WAT, as reflected in gene expression changes and reduced adipocyte size, and 7) dairy foods included in a modest energy restricted diet will decrease inflammation in WAT and other tissues, thus decreasing circulating cytokines, increasing zinc status, decreasing expression of inflammatory markers in WAT, and reducing WAT macrophage infiltration.

Primary Outcome

Weight measured in kg

Conditions Studied

Interventions

  • OTHER high dairy diet
  • OTHER Low Dairy

Study Locations (1)

California

  • Western Human Nutrition Research Center - Davis

Trial Details

FieldValue
Enrollment Target 78 participants
Start Date 2006-10
Est. Completion 2009-08
Phase NA

What the finished NCT00858312 record still lists

NCT00858312 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 78 participants, a relatively small participant target, below the 228-participant average among 115 other Overweight and Obesity trials with a reported enrollment target (66% lower).

The record links to 1 condition, with Overweight and Obesity appearing as the primary indexed condition, and to 2 interventions - of which high dairy diet is the first listed.

NCT00858312 reports a single indexed study location in California.

Frequently Asked Questions

What is clinical trial NCT00858312 about?

NCT00858312 is a clinical study titled "Dairy Foods and Weight Loss". Obesity is a national epidemic with multiple causes and complex solutions. Research in both animals and humans has suggested that the inclusion of dairy foods into a moderate calorie restricted diet can increase weight loss and fat loss. Our proposed project extends these prior findings by determini...

What is the current status of trial NCT00858312?

This trial is currently completed. It is a NA study. The enrollment target is 78 participants. The study started on 2006-10. Estimated completion is 2009-08.

What conditions does trial NCT00858312 study?

This clinical trial studies the following conditions: Overweight and Obesity.

What interventions are being tested in trial NCT00858312?

The interventions under investigation include: high dairy diet (OTHER), Low Dairy (OTHER).

Who is sponsoring clinical trial NCT00858312?

This trial is sponsored by USDA, Western Human Nutrition Research Center, which has 47 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00858312 being conducted?

This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Overweight and Obesity

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT00858312's enrollment target sits among peer trials

78 66th of 115 higher than 50 of 115 other Overweight and Obesity trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Overweight and Obesity trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02397668 · 78 participants · NA

    CorMatrix Cor TRICUSPID ECM Valve Replacement Study

  • NCT03321656 · 78 participants · Phase 2

    Impact of Envarsus XR® on Kidney Biopsy Subclinical Rejection and Blood Immunologic Profile

  • NCT03687814 · 78 participants · NA

    Low FODMAP Plus PEG 3350 for the Treatment of Patients with Irritable Bowel Syndrome-Constipation

  • NCT04018872 · 78 participants · Phase 2

    Evaluating the Effect of Itraconazole on Pathologic Complete Response Rates in Esophageal Cancer

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT00858312, the US trial registry maintained by the National Library of Medicine. NCT00858312 (small enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.